On-chip synthesis of fine-tuned bone-seeking hybrid nanoparticles

Nanomedicine

Volumn 10, Issue 23, 2015, Pages 3431-3449

  Hasani Sadrabadi, Mohammad Mahdi ^a,b,c   Dashtimoghadam, Erfan ^d   Bahlakeh, Ghasem ^e   Majedi, Fatemeh S ^c,f   Keshvari, Hamid ^c   Van Dersarl, Jules J ^b   Bertsch, Arnaud ^b   Panahifar, Arash ^g   Renaud, Philippe ^b   Tayebi, Lobat ^d,h   Mahmoudi, Morteza ^i,j   Jacob, Karl I ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EPFL   (Switzerland)

^c AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^d MARQUETTE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^e GOLESTAN UNIVERSITY   (Iran)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

bisphosphonate; bone targeting; hybrid nanoparticles; microfluidics platform; theragnosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; MULTIFUNCTIONAL BONE SEEKING HYBRID NANOPARTICLE; NANOCARRIER; PACLITAXEL; POLYGLACTIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE TUMOR; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MICROFLUIDICS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TUMOR LOCALIZATION; CHEMISTRY; PROCEDURES;

DIPHOSPHONATES; MICROFLUIDICS; NANOPARTICLES;

EID: 84948980313     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.162     Document Type: Article

References (59)

1. Karsdal M, Christiansen C, Ladel C, Henriksen K, Kraus V, Bay-Jensen A. Osteoarthritis-a case for personalized health care Osteoarthritis Cartilage 22(1), 7-16 (2014).
2. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319), 1761-1767 (2002).
3. Connolly LP, Drubach LA, Treves TS. Applications of nuclear medicine in pediatric oncology. Clin. Nucl. Med. 27(2), 117-125 (2002).
4. Wang K, Allen L, Fung E, Chan CC, Chan JCS, Griffith JF. Bone scintigraphy in common tumors with osteolytic components. Clin. Nucl. Med. 30(10), 655-671 (2005).
5. Huvos AG. Bone Tumors: Diagnosis, Treatment, And Prognosis. WB Saunders, London, UK (1997).
6. Çermik FT, Salan A, Firat FM, Berkarda AS. Tc-99m mdp bone scintigraphy in a patient with multicentric osteosarcoma. Clin. Nucl. Med. 28(7), 599-600 (2003).
7. Kubícek V, Lukeš I. Bone-seeking probes for optical and magnetic resonance imaging. Future Med. Chem. 2(3), 521-531 (2010).
8. Panahifar A, Mahmoudi M, Doschak MR. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl. Mater. Interfaces 5(11), 5219-5226 (2013).
9. Torres Martin De Rosales R, Tavaré R, Glaria A, Varma G, Protti A, Blower PJ. (99m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjug. Chem. 22(3), 455-465 (2011).
10. Lewington V. Cancer therapy using bone-seeking isotopes. Phys. Med. Biol. 41(10), 2027 (1996).
11. Lübbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. J. Surg. Res. 95(2), 200-206 (2001).
12. Mahmoudi M, Hosseinkhani H, Hosseinkhani M et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem. Rev. 111(2), 253-280 (2011).
13. Mahmoudi M, Serpooshan V, Laurent S. Engineered nanoparticles for biomolecular imaging. Nanoscale 3(8), 3007-3026 (2011).
14. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338(6109), 903-910 (2012).
15. Sengupta S, Eavarone D, Capila I et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436(7050), 568-572 (2005).
16. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (spions): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63(1-2), 24-46 (2011).
17. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 112(4), 2323-2338 (2011).
18. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. J. Phys. Chem. B 112(46), 14470-14481 (2008).
19. Benyettou F, Lalatonne Y, Chebbi I et al. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics. Phys. Chem. Chem. Phys. 13(21), 10020-10027 (2011).
20. Matsuoka F, Shinkai M, Honda H, Kubo T, Sugita T, Kobayashi T. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. BioMagn. Res. Technol. 2(1), 3 (2004).
21. Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat. Nano 7(10), 623-629 (2012).
22. Duncanson WJ, Lin T, Abate AR, Seiffert S, Shah RK, Weitz DA. Microfluidic synthesis of advanced microparticles for encapsulation and controlled release. Lab Chip 12(12), 2135-2145 (2012).
23. Jahn A, Stavis SM, Hong JS, Vreeland WN, Devoe DL, Gaitan M. Microfluidic mixing and the formation of nanoscale lipid vesicles. ACS Nano 4(4), 2077-2087 (2010).
24. Karnik R, Gu F, Basto P et al. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 8(9), 2906-2912 (2008).
25. Majedi FS, Hasani-Sadrabadi MM, Vandersarl JJ et al. Onchip fabrication of paclitaxel-loaded chitosan nanoparticles for cancer therapeutics. Adv. Funct. Mater. 24(4), 432-441 (2014).
26. Hasani-Sadrabadi MM, Karimkhani V, Majedi FS et al. Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsules. Adv. Mater. 26(19), 3118-3123 (2014).
27. Majedi FS, Hasani-Sadrabadi MM, Hojjati Emami S et al. Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents. Lab Chip 13(2), 204-207 (2013).
28. Hasani-Sadrabadi MM, Majedi FS, Vandersarl JJ et al. Morphological tuning of polymeric nanoparticles via microfluidic platform for fuel cell applications. J. Am.Chem. Soc. 134(46), 18904-18907 (2012).
29. Song Y, Hormes J, Kumar CSSR. Microfluidic synthesis of nanomaterials. Small 4(6), 698-711 (2008).
30. Marre S, Jensen KF. Synthesis of micro and nanostructures in microfluidic systems. Chem. Soc. Rev. 39(3), 1183-1202 (2010).
31. Pignatello R, Cenni E, Micieli D et al. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. doi: 10.2217/17435889.4.2.161 (2009) (Epub ahead of print).
32. Cenni E, Granchi D, Avnet S et al. Biocompatibility of poly (D, L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials 29(10), 1400-1411 (2008).
33. Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc. Natl Acad. Sci. USA 106(19), 7957-7961 (2009).
34. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26(15), 2685-2694 (2005).
35. Dashtimoghadam E, Mirzadeh H, Taromi FA, Nyström B. Microfluidic self-assembly of polymeric nanoparticles with tunable compactness for controlled drug delivery. Polymer 54(18), 4972-4979 (2013).
36. Sharma S, Ganesh T, Kingston DGI, Bane S. Promotion of tubulin assembly by poorly soluble taxol analogs. Anal. Biochem. 360(1), 56-62 (2007).
37. Chen H, Li G, Chi H et al. Alendronate-conjugated amphiphilic hyperbranched polymer based on Boltorn H40 and poly (ethylene glycol) for bone-targeted drug delivery. Bioconjug. Chem. 23(9), 1915-1924 (2012).
38. Accelrys Software Inc. http://accelrys.com/products/collaborative-science
39. Kay M, Young R, Posner A. Crystal structure of hydroxyapatite. Nature 204, 1050-1052 (1964).
40. Lu X, Zhao Z, Leng Y. Calcium phosphate crystal growth under controlled atmosphere in electrochemical deposition. J. Cryst. Growth 284(3), 506-516 (2005).
41. Xin R, Leng Y, Wang N. In situ TEM examinations of octacalcium phosphate to hydroxyapatite transformation. J. Cryst. Growth 289(1), 339-344 (2006).
42. Sun H. Compass: an ab initio force-field optimized for condensed-phase applications overview with details on alkane and benzene compounds. J. Phys. Chem. B 102(38), 7338-7364 (1998).
43. Sun H, Ren P, Fried J. The compass force field: parameterization and validation for phosphazenes. Comput. Theoret. Polym. Sci. 8(1), 229-246 (1998).
44. Hauptmann S, Dufner H, Brickmann J, Kast SM, Berry RS. Potential energy function for apatites. Phys. Chem. Chem. Phys. 5(3), 635-639 (2003).
45. Swope WC, Andersen HC, Berens PH, Wilson KR. A computer simulation method for the calculation of equilibrium constants for the formation of physical clusters of molecules: application to small water clusters. J. Chem. Phys. 76(1), 637-649 (1982).
46. Hasani-Sadrabadi MM, Vandersarl JJ, Dashtimoghadam E et al. A microfluidic approach to synthesizing highperformance microfibers with tunable anhydrous proton conductivity. Lab Chip 13(23), 4549-4553 (2013).
47. Majedi FS, Hasani-Sadrabadi MM, Vandersarl JJ et al. Onchip fabrication of paclitaxel loaded chitosan nanoparticles for cancer therapeutics. Adv. Funct. Mater. doi:10.1002/adfm.201301628 (2013) (Epub ahead of print).
48. Hasani-Sadrabadi MM, Pour Hajrezaei S, Hojjati Emami S et al. Enhanced osteogenic differentiation of stem cells via microfluidics synthesized nanoparticles. Nanomedicine 11(7), 1809-1819 (2015).
49. Couto R, Chambon S, Aymonier C et al. Microfluidic supercritical antisolvent continuous processing and direct spray-coating of poly(3-hexylthiophene) nanoparticles for OFET devices. Chem. Commun. 51(6), 1008-1011 (2015).
50. Valencia PM, Basto PA, Zhang L et al. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano 4(3), 1671-1679 (2010).
51. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13), 3657-3666 (2010).
52. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41(7), 2971-3010 (2012).
53. Shi J, Xiao Z, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc. Chem. Res. 44(10), 1123-1134 (2011).
54. Luhmann T, Germershaus O, Groll J, Meinel L. Bone targeting for the treatment of osteoporosis. J. Control. Release 161(2), 198-213 (2012).
55. Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials 33(29), 7164-7173 (2012).
56. Ross RD, Roeder RK. Binding affinity of surface functionalized gold nanoparticles to hydroxyapatite. J. Biomed. Mater Res. Part A 99(1), 58-66 (2011).
57. Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos. Int. 19(6), 733-759 (2008).
58. Morton SW, Shah NJ, Quadir MA, Deng ZJ, Poon Z, Hammond PT. Osteotropic therapy via targeted layer-by-layer nanoparticles. Adv. Healthc. Mater. 3(6), 867-875 (2014).
59. Segal E, Pan H, Benayoun L et al. Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances. Biomaterials 32(19), 4450-4463 (2011).